[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100385983":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":24,"responsibleParty":40,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":50,"minAge":10,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},{"fullName":5,"class":6},"Hadassah Medical Organization","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Recurrent Urinary tract infection",null,"Menopausal women, with two or more documented, culture-positive infections in the last six months or ≥3 infections in the last year",{"label":13,"type":10,"description":14,"interventionNames":10},"Healthy controls","Menopausal women, without prior history of UTIs or other urologic abnormalities.",[16],{"name":17,"affiliation":5,"role":18},"Ahinoam Lev-Sagie, MD","PRINCIPAL_INVESTIGATOR",[20],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","97225844000","levsagie@netvision.net.il",[25],{"facility":26,"status":27,"city":28,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Hadassah Medical Center","RECRUITING","Jerusalem","9765422","Israel","IL",{"type":33,"coordinates":34},"Point",[35,36],35.21633,31.76904,{"lat":36,"lon":35},[39],{"name":17,"role":21,"phone":10,"phoneExt":10,"email":10},{"type":18,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Ahinoam Lev-Sagie","MD","100385983","characterization-of-vaginal-urinary-and-fecal-microbiomes-in-women-with-recurrent-urinary-tract-infections-100385983",false,"NCT04305808","Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections","Patients' inclusion criteria:\n\n* Menopausal status\n* Two or more documented, culture-positive infections in the last six months or ≥3 infections in the last year Patients' exclusion criteria\n* Neurogenic bladder condition\n* Known immunodeficiencies\n* Usage of antibiotics or probiotics within the previous month\n* Known renal calculi or anatomic malformations\n\nControl subjects- Inclusion criteria:\n\n* Menopausal status\n* Sterile urine cultures, normal urinalysis, and negative sexually-transmitted PCR urine assay\n\nControl subjects- Exclusion criteria:\n\n\\- A prior history of UTIs or other urologic abnormalities.",true,"FEMALE",{"count":52,"type":53},40,"ESTIMATED","OBSERVATIONAL","The objectives are to evaluate whether variations in vaginal and\u002For urinary and\u002For fecal microbiome predispose postmenopausal women to recurrent cystitis. This will be explored using comparison of microbiome profiles between those with recurrent UTI compared to age-matched women without recurrent UTI.",[57,58],"Urinary Tract Infections","Menopause","2025-03-15",{"date":61,"type":62},"2025-03-19","ACTUAL",{"date":64,"type":62},"2021-08-01",{"date":66,"type":53},"2025-12-30",{"name":5,"class":6},1]